Workflow
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi's 2025 SMID Cap Biopharma Call Series Transcript

PresentationYigal NochomovitzCitigroup Inc., Research Division All right. Great. Hopefully, everyone is connected. Well, I'm Yigal Nochomovitz, biotech analyst here at Citi in New York City. It is my pleasure to introduce the next iteration in our virtual C-suite fireside chat series with Yujiro Hata, who, of course, needs no introduction, the CEO of IDEAYA. If you guys have questions for Yujiro during the course of the conversation, please e-mail me, yigal.nochomovitz@citi.com, and I will hopefully see th ...